The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer;Intérêt de la tomographie par émission de positons au [18F]-fluoro-2-désoxyglucose dans la détermination des volumes cibles de radiothérapie. Application à l'irradiation conformationnelle des cancers bronchiques non à petites cellules

Cancer/Radiotherapie

Volumn 9, Issue 8, 2005, Pages 602-609

  Bachaud, J M ^a   Marre, D ^a   Dygai, I ^a   Caselles, O ^a   Hamelin, D ^a   Begue M ^a   Laprie, A ^a   Zerdoud, S ^a   Gancel, M ^a   Courbon, F ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

FDG PET; Non small cell lung cancer; Radiation therapy; Radiotherapy planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ATELECTASIS; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGING; LUNG NON SMALL CELL CANCER; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION FIELD; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 29144490067     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.09.015     Document Type: Article

References (39)

1. G. Antoch, L.S. Freudenberg, J. Stattaus, W. Jentzen, S.P. Mueller, and J.F. Debatin Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials AJR Am. J. Roentgenol. 179 2002 1555 1560
2. L. Boucher, S. Rodrigue, R. Lecomte, and F. Benard Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results J. Nucl. Med. 45 2004 214 219
3. J. Bradley, W.L. Thorstad, S. Mutic, T.R. Miller, F. Dehdashti, and B.A. Siegel Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 59 2004 78 86
4. J.D. Bradley, C.A. Perez, F. Dehdashti, and B.A. Siegel Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer J. Nucl. Med. 45 2004 96S 101S
5. C.B. Caldwell, K. Mah, M. Skinner, and C.E. Danjoux Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int. J. Radiat. Oncol. Biol. Phys. 55 2003 1381 1393
6. C.B. Caldwell, K. Mah, Y.C. Ung, C.E. Danjoux, J.M. Balogh, and S.N. Ganguli Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion Int. J. Radiat. Oncol. Biol. Phys. 51 2001 923 931
7. R.J. Cerfolio, B. Ojha, A.S. Bryant, C.S. Bass, A.A. Bartalucci, and J.M. Mountz The role of FDG-PET scan in staging patients with nonsmall cell carcinoma Ann. Thorac. Surg. 76 2003 861 866
8. I.F. Ciernik, E. Dizendorf, B.G. Baumert, B. Reiner, C. Burger, and J.B. Davis Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 57 2003 853 863
9. C. Cohade, M. Osman, Y. Nakamoto, L.T. Marshall, J.M. Links, and E.K. Fishman Initial experience with oral contrast in PET/CT: phantom and clinical studies J. Nucl. Med. 44 2003 412 416
10. D.C. Collier, S.S. Burnett, M. Amin, S. Bilton, C. Brooks, and A. Ryan Assessment of consistency in contouring of normal-tissue anatomic structures J. Appl. Clin. Med. Phys. 4 2003 17 24
11. J.F. Daisne, M. Sibomana, A. Bol, T. Doumont, M. Lonneux, and V. Gregoire Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother. Oncol. 69 2003 247 250
12. E. Dizendorf, T.F. Hany, A. Buck, G.K. Von Schulthess, and C. Burger Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies J. Nucl. Med. 44 2003 732 738
13. E.V. Dizendorf, B.G. Baumert, G.K. Von Schulthess, U.M. Lutolf, and H.C. Steinert Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy J. Nucl. Med. 44 2003 24 29
14. Y.E. Erdi, K. Rosenzweig, A.K. Erdi, H.A. Macapinlac, Y.C. Hu, and L.E. Braban Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Radiother. Oncol. 62 2002 51 60
15. C. Fiorino, M. Reni, A. Bolognesi, G.M. Cattaneo, and R. Calandrino Intra- and inter-observer variability in contouring prostate and seminal vesicles: implications for conformal treatment planning Radiother. Oncol. 47 1998 285 292
16. P. Giraud, S. Elles, S. Helfre, R.Y. De, V. Servois, and M.F. Carette Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists Radiother. Oncol. 62 2002 27 36
17. P. Giraud, D. Grahek, F. Montravers, M.F. Carette, E. Deniaud-Alexandre, and F. Julia CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1249 1257
18. P. Giraud, S. Helfre, A. Lavole, J.C. Rosenwald, and J.M. Cosset Cancers bronchiques non ̀ petites cellules : aḿlioration des chances de survie par la radioth́rapie conformationnelle? Cancer Radiother. 6 2002 125 134
19. G.W. Goerres, G.K. Von Schulthess, and H.C. Steinert Why most PET of lung and head-and-neck cancer will be PET/CT J. Nucl. Med. 45 2004 66S 71S
20. V. Gregoire Is there any future in radiotherapy planning without the use of PET: unraveling the myth Radiother. Oncol. 73 2004 261 263
21. G. Halter, A.K. Buck, H. Schirrmeister, E. Aksoy, F. Liewald, and G. Glatting Lymph node staging in lung cancer using [18F]FDG-PET Thorac. Cardiovasc. Surg. 52 2004 96 101
22. C.L. Holloway, D. Robinson, B. Murray, J. Amanie, C. Butts, and M. Smylie Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer Radiother. Oncol. 73 2004 285 287
23. J.D. Kiffer, S.U. Berlangieri, A.M. Scott, G. Quong, M. Feigen, and W. Schumer The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer Lung Cancer 19 1998 167 177
24. D. Lardinois, W. Weder, T.F. Hany, E.M. Kamel, S. Korom, and B. Seifert Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N. Engl. J. Med. 348 2003 2500 2507
25. M.P. Mac Manus, R.J. Hicks, D.L. Ball, V. Kalff, J.P. Matthews, and E. Salminen F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment Cancer 92 2001 886 895
26. M.P. Mac Manus, K. Wong, R.J. Hicks, J.P. Matthews, A. Wirth, and D.L. Ball Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center Int. J. Radiat. Oncol. Biol. Phys. 52 2002 351 361
27. M.P. MacManus, R.J. Hicks, J.P. Matthews, A. Hogg, A.F. McKenzie, and A. Wirth High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 50 2001 287 293
28. K. Mah, C.B. Caldwell, Y.C. Ung, C.E. Danjoux, J.M. Balogh, and S.N. Ganguli The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int. J. Radiat. Oncol. Biol. Phys. 52 2002 339 350
29. F. Mornex, P. Loubeyre, P. Giraud, O. Chapet, P. Van Houtte, and P. Bonnette Volume tumoral macroscopique et volume cible anatomoclinique en radioth́rapie:: cancer bronchique Cancer Radiother. 5 2001 659 670
30. M.T. Munley, L.B. Marks, C. Scarfone, G.S. Sibley, E.F. Patz Jr., and T.G. Turkington Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects Lung Cancer 23 1999 105 114
31. U. Nestle, K. Walter, S. Schmidt, N. Licht, C. Nieder, and B. Motaref 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int. J. Radiat. Oncol. Biol. Phys. 44 1999 593 597
32. H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer J. Thorac. Cardiovasc. Surg. 127 2004 1087 1092
33. A.C. Paulino, and P.A. Johnstone FDG-PET in radiotherapy treatment planning: Pandora's box? Int. J. Radiat. Oncol. Biol. Phys. 59 2004 4 5
34. F. Reboul, L. Mineur, J.B. Paoli, V. Baudez, R. Oozeer, and R. Garcia Radioth́rapie thoracique et contrôle de la respiration:: perspectives actuelles Cancer Radiother. 6 2005 135 139
35. S. Senan, D.K. Van Sornsen, M. Samson, H. Tankink, P. Jansen, and P.J. Nowak Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer Radiother. Oncol. 53 1999 247 255
36. A. van Der Wel, S. Nijsten, M. Hochstenbag, R. Lamers, L. Boersma, and R. Wanders Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study Int. J. Radiat. Oncol. Biol. Phys. 61 2005 649 655
37. H. van Tinteren, O.S. Hoekstra, E.F. Smit, J.H. van den Bergh, A.J. Schreurs, and R.A. Stallaert Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1393
38. L.J. Vanuytsel, J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn, W. De Wever, and E.K. Verbeken The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother. Oncol. 55 2000 317 324
39. W.V. Vogel, W.J. Oyen, J.O. Barentsz, J.H. Kaanders, and F.H. Corstens PET/CT: panacea, redundancy, or something in between? J. Nucl. Med. 45 2004 15S 24S